Disclaimer

The readiness score, GTM archetype, peer benchmark and execution-gap figures are indicative strategic signals. They are generated automatically from the answers you supply, using a structured commercialisation framework. They are not an audit, a valuation, a due-diligence report, or a verified assessment of your venture.

Every figure is derived from self-reported information. We do not independently verify what is submitted. Incomplete, optimistic or inaccurate answers will produce a correspondingly unreliable output.

Nothing produced by these tools constitutes investment, financial, legal, regulatory, tax, clinical, medical or accounting advice. Deep-tech, oncology and life-science commercialisation involves regulatory, clinical and reimbursement pathways that require qualified specialist counsel. Always take appropriate professional advice before making a decision that carries commercial, clinical or legal consequence.

Benchmarks reflect patterns we have observed across comparable ventures. They are not predictions. No commercial result — funding, partnership, revenue, adoption or exit — is promised, implied or guaranteed by any score, archetype or recommendation produced here.

You are solely responsible for any action taken on the basis of a diagnostic output. To the fullest extent permitted by law, DGB Strategy accepts no liability for loss or damage arising from reliance on the tools or their results.

References to accelerators, programmes, funders or organisations are for context only and do not imply endorsement, affiliation or partnership in either direction unless expressly stated.